Traws Pharma Inc (TRAW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,170 | -166,523 | -18,948 | -18,964 | -16,163 |
| Depreciation Amortization | 61 | 12 | 16 | 14 | 14 |
| Accounts receivable | -2,029 | -1,747 | 11 | -1 | 9 |
| Accounts payable and accrued liabilities | -612 | 646 | 1,759 | 1,103 | -2,076 |
| Other Working Capital | -1,577 | -6,573 | -301 | 1,484 | -3,593 |
| Other Operating Activity | -23,198 | 144,393 | -469 | 70 | 2,322 |
| Operating Cash Flow | $-18,185 | $-29,792 | $-17,932 | $-16,294 | $-19,487 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -14 | N/A | N/A |
| Net Acquisitions | N/A | -3,648 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -2,585 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2,585 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,585 | $-3,648 | $-14 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,582 | 33,976 | N/A | N/A | 55,560 |
| Other Financing Activity | -2,378 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $3,204 | $33,976 | $0 | $N/A | $55,560 |
| Exchange Rate Effect | 48 | -19 | 10 | -19 | -28 |
| Beginning Cash Position | 21,338 | 20,821 | 38,757 | 55,070 | 19,025 |
| End Cash Position | 3,820 | 21,338 | 20,821 | 38,757 | 55,070 |
| Net Cash Flow | $-17,518 | $517 | $-17,936 | $-16,313 | $36,045 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,185 | -29,792 | -17,932 | -16,294 | -19,487 |
| Capital Expenditure | N/A | N/A | -14 | N/A | N/A |
| Free Cash Flow | -18,185 | -29,792 | -17,946 | -16,294 | -19,487 |